Monday 16 November
Session: Frontiers of life sciences – 9.15am-12.30pm
London Life Sciences Week Pavilion, 180 Studios
Agenda:
9.15am – Registration and welcome coffee
10am – Chair’s address
-Samantha Simmonds
10.05am – Keynote introduction
-Laura Citron OBE, CEO, London & Partners
10.10am – London: Europe’s frontier innovation capital
VIP speaker
10.15am – The UK life sciences sector plan: Progress and priorities
VIP speaker
10.20am – Unlocking the power of genomics and health data
Baroness Nicola Blackwood, Chair, Health Data Research Service.
10.25am – The AI revolution in drug discovery
Dr Rosie Rodriguez, President of Growth, Relation
Dr Dave Hallett, Chief Scientific Officer, Recursion Pharmaceuticals
Moderator: Dr Junaid Bajwa, Senior Partner, Flagship Pioneering
10.45am – Coffee break
11.05am – Chair’s address
Samantha Simmonds
11.10am – Sponsor’s address – The life sciences landscape: Capital, innovation and strategic opportunity
Gil Bar-Nahum, Managing Director and Head of Biotechnology, EMEA, Jefferies
11.15am – How smart materials are shaping biology
Professor Dame Molly Stevens, John Black Professor of Bionanoscience, University of Oxford
11.25am – Regulating and investing in emerging technologies: What’s next?
Dr Kath Mackay, Managing Director, Innovate UK
Dr Ed Middleton, Director of Strategy, Medicines and Healthcare Regulatory Agency
Dr Vishal Gulati, Founder and Managing Partner, Recode Sciences Group
Prof Paul Kellam, CSO and Cofounder, RQ Bio Ltd., Prof Virus Genomics, Imperial College London
Moderator: Max Stanyard, Senior Analyst, Life Sciences and Healthcare, RSM
11.50am – The next operating model for biotech
Manish Gupta, Chairman and CEO, Indegene
Renée Aguiar-Lucander, CEO, Hansa Biopharma
Steve Bates OBE, Executive Chair, Office for Life Sciences
Verena Stocker, Regional Head, Lilly Gateway Labs, Eli Lilly
Moderator: Dr Sam Barrell CBE, CEO, LifeArc
12.15pm – Chair’s closing remarks
Samantha Simmonds
12.20pm – Lunch
1.30pm – Close
Session: Global Frontiers – 2pm-4.50pm
London Life Sciences Week Pavilion, 180 Studios.
2pm – Registration and welcome coffee
2.30pm – Introduction to the Global Frontiers session
Dr Angela Kukula, Special Advisor, London and Partners
2.35pm – Global frontiers: Rise of East Asia
John Edwards, Director, Office for Investment
2.40pm – 200 years of UCL: shaping the next frontier of global science
Professor Geraint Rees, Vice-Provost, Research, Innovation and Global Engagement, UCL
2.55pm – City spotlight: Shanghai
Jack Zhang, London representative, Invest Shanghai
3.05pm – City spotlight: Singapore
Mr Pengfei Chen, Vice President Healthcare Division, Singapore Economic Development Board
3.15pm – Bridge between UK and East Asia for new therapeutics companies
Dr Yinfei Yin, Senior Vice President and Head of Biology, Business Development and Marketing, ChemPartner
Dr Yoshiro Shiba, Associate Director, Global Innovation, External Innovation, Shionogi Europe
Ms Xinyue Zhang, Vice President and COO, United Imaging Europe
Colin Tan, TUSPark
Dr Lisa Campbell, Richmond Pharmacology
Moderator: Dr Ivana Poparic, Director – Business Development and Strategic Advisory, Ramboll
3.35pm – Chair’s closing remarks
John Edwards, Director Investment, OFI
3.40pm – Coffee break
4pm – Chair’s address
John Edwards, Director Investment, OFI
4.05pm – City spotlight: Tokyo
Dr Ikuo Hayashi, President and COO, LINK-J
4.15pm – Regulation and market access: How to sell your product in East Asia
Dr Nik Sharma, CEO and Co-Founder, BioCorteX
Tetsu Yung, Tetsunagi consulting
Jurie Hwang, Director of Public and International Affairs, KoreaBIO
Moderator: Dr Angela Kukula, Special Advisor, London & Partners
4.40pm – How London & Partners supports international trade
Rik Patel, Senior Trade Manager, London & Partners
4.50pm – Chair’s closing remarks
John Edwards, Director, Office for Investment
Tuesday 17 November
Session: Frontiers of patient care – 10am-12.20pm
London Life Sciences Week Pavilion, 180 Studios.
Agenda
9.15am – Registration and welcome coffee
10am – Chair’s address
Hannah Witty, Regional Chief Financial Officer and Deputy Chief Executive Officer, NHS England (London)
10.05am – The London million hearts and minds challenge
Professor Kevin Fenton CBE, Regional Public Health Director, Public Health England
10.15am – Data in action: Transforming patient outcomes through data
Andrew Miles, Chief Business Officer, Our Future Health
Dr Natalie Banner, Chief Ethics and Engagement Officer, Genomics England
Moderator: Dr Dominique Allwood, CEO, Imperial College Health Partners
10.30am – Driving innovation in healthcare: The role of the private sector
Adnan Iqbal, Co-Founder and CEO, Luma Health
Edward Ungar, CEO, Pharmacierge
Professor Jenny Shand, Strategic Advisor, Harley Street Health District
Dr Vikas Mehta, Head of Executive Health, Cedars Sinai
Moderator: Professor Ian Abbs, Chair of Science and Innovation, Reef + Partners
10.50am – Closing remarks
Hannah Whitty, NHS London Regional Director, NHS England
10.55am – Coffee break
11.20am – Welcome back
Hannah Whitty, Regional Chief Financial Officer and Deputy Chief Executive Officer, NHS England (London)
11.25am – Reimagining women’s health: Technology and the future of endometriosis care
Dr Thomas Bainton, Consultant Obstetrician and Gynaecologist, Chelsea and Westminster Hospital
Dr Philip Pratt, CTO, Medical iSight
Moderator: Dr Veronique Bouchet, CMO, PrecisionLife
11.40am – Harnessing digital and innovation to reduce health inequalities in London
Caroline Clarke, CEO, Online NHS Trust
Dr Rishi Das Gupta, CEO, South London Health Innovation Network
11.50am – The future of cancer care
Professor Susana Banerjee, Consultant Medical Oncologist, Royal Marsden Hospital
Professor Lars Erwig, Director of Centre for Drug Development, Cancer Research UK
Moderator: Dr Chris Laing, CEO, UCL Partners
12.15pm – Chair’s closing remarks
Hannah Witty, Regional Chief Financial Officer and Deputy Chief Executive Officer, NHS England (London)
12.20pm – Lunch
Session: Cancer innovators forum – 1.30pm-5.35pm
London Life Sciences Week Pavilion, 180 Studios.
Agenda
1.30pm – Registration and welcome coffee
2pm – Welcome address
Tanya Hughes, Stakeholder Relations Lead, Cancer Research Horizons
2.05pm – Opening address
Dr Jon Wilkinson, Director of Business and Innovation, Institute of Cancer Research
2.10pm – Opening keynote
Chris McDonald MP, Minister of State, Minister for Science, Innovation and Investment
2.20pm – The future of cancer science
Tony Ng, Senior Vice president, Oncology Translational Research, GSK
2.40pm – Cutting-edge science: From discovery to the clinic
Professor Juanita Lopez – Consultant Medical Oncologist, RMH (ICR)
Steve Wedge – CSO of Therapeutic Innovation, CRH
Fiona MacLaughlin, VP Venture Investments, Johnson and Johnson Innovation
Professor Mark Middleton, Head of Oncology Oxford University
Moderator: Dr Olivia Rossanese, Director of the Centre for Cancer Drug Discovery and Head of Division for Cancer Therapeutics, ICR
3.20pm – Closing remarks
Tanya Hughes, Stakeholder Relations Lead, Cancer Research Horizons
3.20pm – Coffee break
3.40pm – Welcome back
Tanya Hughes, Stakeholder Relations Lead, Cancer Research Horizons
3.40pm – Place-based innovation: Clusters, ecosystem and community
Barry Jessup, Chief Executive, Socius (on behalf of London Cancer District)
Dr Suki Balendra, Director of Strategic Partnerships, Paddington Life Sciences
Moderator: Emily Wright, The Times, Dezeen
4.05pm – Where is the money?
Tony Hickson, Chief Business Officer, Cancer Research Horizons
4.25pm – Investment and the funding landscape
Simon Boulton, founder ALTx Therapeutics
Umaima Ahmad, CEO and Co-Founder 52 North
Olivia Cavlan, LifeArc Ventures
Jess McCreadie, Aviva Investors
Moderator: Tony Hickson, Chief Business Officer, Cancer Research Horizons
5.05pm – Keynote address
Professor Peter Johnson, National Clinical Director for Cancer at NHS England and Chair of the UK Office for Life Sciences Cancer Goal
5.20pm – Closing remarks
Tanya Hughes, Stakeholder Relations Lead, Cancer Research Horizons
5.25pm – Drinks reception and networking
Wednesday 18 November
Session: New frontiers showcase – 8am-12.55pm
London Life Sciences Week Pavilion, 180 Studios
Agenda
8am – Early-Stage investor breakfast
9.30am – Networking, registration and welcome coffee
10am – Chair’s address
Reya El-Salahi
10.05am – Keynote address
Dr Anne Lane, CEO, UCL Ventures
10.10am – Investor panel
Katie Lockwood, TwinPath Ventures
Oliver Sexton, Future Planet Capital
Hayley Cross, Mishcon Plus
Moderator: Sunil Shah o2h Ventures
10.30am – Pitches: Pre-seed and seed
Nilocas, Queen Mary University
ChemKAS, Kings
Neobe Therapeutics, CRH
PentaBind
TestaVec Ltd, Brunel
11am – Coffee break
1.45am – Pitches: Seed and Series A
Pentabind, TechBio Boost
Eye2Gene, UCL Ventures
Axiom Theraputics, Grow London Global
iLOF, Grow London Global
OSSTECH, Mishcon Plus
Echopoint, UCL Ventures
Sentinal 4D, Institute of Cancer Research
12.10pm – Fireside chat: In conversation with GSK and Johnson & Johnson
Toby Richardson, Senior Director, External Scientific Innovation for Johnson & Johnson EMEA
Jeannie Rojas, Senior Director, Transactions, Worldwide Business Development, GSK
Moderator: Richard Butt, Apollo Therapeutics
12.40pm – Feedback and prizes
Reya El-Salahi
12.50pm – Chair’s closing remarks
Reya El-Salahi
12.55pm – Lunch
Session: Real challenges, practical solutions: A guide for life sciences founders – 2pm-4.50pm
Agenda
2pm – Registration and welcome coffee
2.30pm – Introduction
Dr. Alessia Errico, Associate Director, Search and Evaluation, Entrepreneurial Programmes Lead, Cancer Research Horizons
Patrick Farrant, Partner, Innovation Department, Head of the Life Sciences Group, Mishcon de Reya
2.40pm – From spinout to scale: The decisions nobody prepares you for
Prof. Edward Tate, GSK Chair in Chemical Biology, Imperial College London, Satellite Group Leader, Francis Crick Institute, Founder, Myricx Bio and Siftr Bio
Moderator: Tony Hickson, Chief Business Officer, Cancer Research UK, Cancer Research Horizons
3.05pm – Founder challenge
Patrick Farrant, Partner, Innovation Department, Head of the Life Sciences Group, Mishcon de Reya
Simon Youlton, Director, Early Strategic Partnerships UK, Novartis BioMedical Research, Novartis
Liz Hunter, Partner, Remuneration and Incentives, Mishcon de Reya
Chris Keen, Partner, Corporate Department, Head of the Emerging Companies group, Mishcon de Reya
Dr Tanya Moore, Investment Principal, Cancer Research Horizons
3.50pm – Coffee break and expert huddles
4.50pm – Close